Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Video

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

June 26, 2018

Video

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

June 26, 2018

Video

SHDS 2018: Point: A Minimalist Strategy Should be Used in ALL TAVR Patients!

July 4, 2018

Video

SHDS 2018: Perspectives From the NEW Multi-society (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

June 26, 2018

Video

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

June 26, 2018

Video

» Live Case

SHDS 2018: Live Cases #9: University of Washington Medical Center/Regional Heart Center, Seattle, WA - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #6: St. Paul’s Hospital, Vancouver, Canada - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #4: St. Paul’s Hospital, Vancouver, Canada - TAVR

June 26, 2018

Video

SHDS 2018: Keynote Lecture #3: A Deep Dive Into TAVR Cost-Effectiveness Studies - Take Home Messages

July 4, 2018

Video

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

July 4, 2018

Video

SHDS 2018: Full body Embolic Protection During TAVR: The FILTEREX System

June 26, 2018

Video

SHDS 2018: A New Transcatheter Self-Expanding TAVR System - FoldaValve: Design Concept and Preclinical Studies

June 26, 2018

Advertisement

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

SHDS 2018: Point: A Minimalist Strategy Should be Used in ALL TAVR Patients!

SHDS 2018: Perspectives From the NEW Multi-society (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

SHDS 2018: Live Cases #9: University of Washington Medical Center/Regional Heart Center, Seattle, WA - TAVR

SHDS 2018: Live Case #6: St. Paul’s Hospital, Vancouver, Canada - TAVR

SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR

SHDS 2018: Live Case #4: St. Paul’s Hospital, Vancouver, Canada - TAVR

SHDS 2018: Keynote Lecture #3: A Deep Dive Into TAVR Cost-Effectiveness Studies - Take Home Messages

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

SHDS 2018: Full body Embolic Protection During TAVR: The FILTEREX System

SHDS 2018: A New Transcatheter Self-Expanding TAVR System - FoldaValve: Design Concept and Preclinical Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content